Medicinefrom24/7 Wall St.1 day agoIs Trump Going to Kill the GLP-1 Cash Cow?GLP-1 obesity and diabetes drugs produced massive profits for Novo Nordisk and Eli Lilly, funding factory expansions while political moves threaten steep price cuts.